Net Worth Advisory Group’s AbbVie ABBV Stock Holding History

Net Worth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Sell	4,779 -2,222	-32%	-$478K	0.3%	63
2026 Q1	$1.52M	Buy	7,001 +932	+15%	+$207K	0.32%	68
2025 Q4	$1.39M	Buy	6,069 +2,244	+59%	+$511K	0.28%	67
2025 Q3	$886K	Sell	3,825 -2,285	-37%	-$465K	0.26%	74
2025 Q2	$1.13M	Buy	6,110 +2,434	+66%	+$452K	0.25%	79
2025 Q1	$770K	Buy	3,676 +91	+3%	+$17.7K	0.24%	87
2024 Q4	$637K	Buy	3,585 +24	+0.7%	+$4.41K	0.19%	123
2024 Q3	$703K	Buy	+3,561	New	+$665K	0.21%	117

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Net Worth Advisory Group's ABBV Position: Q2 2026 in Review

Net Worth Advisory Group reduced its AbbVie (ABBV) stake by 32% in Q2 2026, selling an estimated $478K and leaving 4,779 shares worth $1.2M. The position accounts for 0.3% of the portfolio, ranked #63.

Net Worth Advisory Group first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.52M in Q1 2026. 901 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Net Worth Advisory Group held 4,779 shares of AbbVie worth $1.2M as of Q2 2026.
Net Worth Advisory Group sold 2,222 AbbVie shares in Q2 2026, an estimated $478K.
AbbVie made up 0.3% of Net Worth Advisory Group's portfolio in Q2 2026, its #63 holding.
Net Worth Advisory Group first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
Net Worth Advisory Group's AbbVie position peaked at $1.52M in Q1 2026.
901 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.